|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 21.17 USD | -3.90% |
|
+5.01% | +120.29% |
| 07-30 | B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating | MT |
| 07-30 | Barrington Raises Price Target on Anika Therapeutics to $21 From $17, Keeps Outperform Rating | MT |
| Market Cap | 283M 246M 230M 210M 395M 27.04B 401M 2.71B 1.06B 13.54B 1.06B 1.04B 45.15B | P/E 2026 * |
-2,117x | P/E 2027 * | 45.5x |
|---|---|---|---|---|---|
| Enterprise Value | 283M 246M 230M 210M 395M 27.04B 401M 2.71B 1.06B 13.54B 1.06B 1.04B 45.15B | EV / Sales 2026 * |
2.32x | EV / Sales 2027 * | 2.2x |
| Free-Float |
79.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Anika Therapeutics, Inc.
| 1 day | -3.90% | ||
| 1 week | +5.01% | ||
| Current month | +9.80% | ||
| 1 month | +34.24% | ||
| 3 months | +43.04% | ||
| 6 months | +107.35% | ||
| Current year | +120.29% |
| 1 week | 20.42 |  | 22.88 |
| 1 month | 14.58 | | 22.88 |
| Current year | 9.01 | | 22.88 |
| 1 year | 8.22 | | 22.88 |
| 3 years | 7.87 | | 29.12 |
| 5 years | 7.87 | | 45.81 |
| 10 years | 7.87 | | 75.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Griffin
CEO | Chief Executive Officer | 40 | 2026-01-31 |
Dawn J. Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 2023-08-31 |
Mira Leiwant
CTO | Chief Tech/Sci/R&D Officer | - | 2019-10-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheryl Blanchard
CHM | Chairman | 61 | 2026-01-31 |
John Henneman
CHM | Chairman | 64 | 2024-02-23 |
Stephen Richard
BRD | Director/Board Member | 63 | 2020-09-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/4/26 | Buy | Director | 1,000 | 0.0075% | ||
| 2/1/26 | Other | Chief Executive Officer | 440,609 | 3.0553% | ||
| 6/20/25 | Free | Director | 14,164 | 0.0967% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.90% | +5.01% | +133.15% | +15.18% | 283M | |
| +0.32% | +3.07% | -14.01% | +5.66% | 193B | |
| -0.20% | +5.42% | -2.51% | +8.54% | 116B | |
| -1.32% | -4.62% | +6.52% | +65.45% | 59.16B | |
| +0.32% | +3.92% | +38.42% | +65.14% | 55.75B | |
| -0.88% | +2.77% | -7.14% | -35.54% | 49.57B | |
| +0.75% | +10.19% | +14.41% | -18.09% | 34.52B | |
| +0.23% | +3.10% | - | - | 31.22B | |
| -1.74% | -0.70% | +40.59% | -12.31% | 24.36B | |
| +1.98% | +12.62% | -2.80% | +25.91% | 24.25B | |
| Average | -0.44% | +4.18% | +22.96% | +13.33% | 58.76B | |
| Weighted average by Cap. | -0.05% | +3.54% | +1.15% | +13.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 122M 106M 99.33M 90.57M 170M 11.67B 173M 1.17B 457M 5.84B 459M 449M 19.48B | 129M 111M 104M 95.25M 179M 12.27B 182M 1.23B 480M 6.14B 483M 472M 20.49B |
| Net income | -67.5K -58.51K -54.85K -50.01K -94.1K -6.44M -95.61K -646K -252K -3.22M -253K -248K -10.76M | 6.42M 5.57M 5.22M 4.76M 8.95M 613M 9.1M 61.46M 23.99M 307M 24.12M 23.59M 1.02B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | US$21.17 | -3.90% | 102,066 |
| 26-08-12 | US$22.03 | +3.77% | 141,049 |
| 26-08-11 | US$21.23 | +2.66% | 114,214 |
| 26-08-10 | US$20.68 | -3.45% | 125,989 |
| 26-08-07 | US$21.42 | +6.25% | 183,568 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANIK Stock
Select your edition
All financial news and data tailored to specific country editions
